FDA approves new cell corrector medication – TRIKAFTA.
I have two copies of the F508del mutation – the most common mutation.
This is not a “cure” but, and a big BUT – this one medication has the potential to help 90% of the population. Let us hope!
Vertex Pharmaceuticals is making more dreams possible. Exciting times, brings tears to my eyes.
Read full press release below.